Skip to main content

Table 1 Preoperative characteristics of patients

From: A novel technique for lymphadenectomy along the left recurrent laryngeal nerve during minimally invasive esophagectomy: a retrospective cohort study

 

ESLR group (n = 291)

Conventional group (n = 102)

P

Age (years)

60.79 ± 7.96

59.72 ± 8.80

0.253

Gender (n)

  

0.211

 male

241(82.82%)

90(88.24%)

 

 female

50(17.18%)

12(11.76%)

 

Comorbidity (n)

   

 Hypertension

105(36.08%)

34(33.33%)

0.633

 Diabetes

41(14.09%)

12(11.76%)

0.617

 COPD

32(11.00%)

15(14.71%)

0.375

 Others

21(7.22%)

9(8.82%)

0.665

Tumour locationa (n)

  

0.728

 Upper thoracic

21(7.22%)

5(4.91%)

 

 Middle thoracic

162(55.67%)

59(57.84%)

 

 Lower thoracic

108(37.11%)

38(37.25%)

 

Clinical stages (n)

  

0.888

 I

43(14.78%)

13(12.75%)

 

 II

187(64.26%)

67(65.69%)

 

 III

61(20.96%)

22(21.56%)

 

 Neoadjuvant treatment (n)

97(33.33%)

30(29.41%)

0.274

Surgeons (n)

  

0.222

 Doctor 1

105(36.08%)

30(29.41%)

 

 Doctor 2

186(63.92%)

72(70.59%)

 
  1. ESLR Elastic suspension of left recurrent laryngeal nerve, COPD Chronic obstructive pulmonary disease. a Upper thoracic From the level of superior aperture of thorax to the level of inferior edge of the azygos arch. Middle thoracic From the level of the inferior edge of the azygos arch to the level of the inferior edge of the inferior pulmonary vein. Lower thoracic From the level of the inferior edge of the inferior pulmonary vein to the esophagogastric junction